Cardiovascular Risk After Preeclampsia

Save

Report Abuse

Description

Investigation of cardiovascular risk 5-15 years after early or late-onset preeclampsia by adenosine stress Magnetic Resonance Imaging and non-invasive methods like retinal vessel analysis, skin measurement of advanced glycation end products, flow-mediated dilation or pulse wave analysis in comparison to women after healthy pregnancies.

Targeted Conditions

Study Overview

Start Date
April 4, 2022
Completion Date
April 1, 2026
Enrollment
60
Date Posted
March 14, 2022
Accepts Healthy Volunteers?
Yes
Gender
Female

Locations

Full Address
Experimental and Clinical Research Center
Berlin 13125, Germany

Eligibility

Study Population
Woman 5-15 years after pregnancy
Minimum Age (years)
18
Maximum Age (years)
60
Eligibility Criteria
Inclusion Criteria:

Women
18-60 years
5-15 years postpartum

Exclusion Criteria:

Atrioventricular block, chronic obstructive pulmonary disease, bronchial asthma
Pregnancy and/or active breastfeeding
Glaucoma disease, epilepsy
In addition for MRI: metal implants, electric devices, intolerance of contrast media, claustrophobia, renal or hepatic dysfunction (GFR < 30 ml/min)

Study Contact Info

Study Contact Name
Kristin Kräker, PhD
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Cardiovascular Risk After Preeclampsia 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
NCTid (if applicable)
NCT05277233